Business context and reporting period
3D Systems Corporation (NYSE: DDD) filed this Form 10-K for the fiscal year ended December 31, 2022. Although the request references 2022 Q4, the supplied filing reports full-year results; it does not provide a clear standalone fourth-quarter financial summary. The company sells 3D printers, materials, software and services through Healthcare Solutions and Industrial Solutions.
Key financial metrics
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $538.0 million | $615.6 million |
| Gross profit / margin | $214.2 million / 39.8% | $263.8 million / 42.8% |
| Operating loss | $117.0 million | $33.1 million |
| Net income (loss) attributable to 3D Systems | $(122.7) million | $322.1 million |
| Basic and diluted EPS | $(0.96) | $2.62 basic; $2.55 diluted |
| Cash from (used in) operating activities | $(70.0) million | $48.1 million |
At year-end, cash and cash equivalents were $388.1 million and short-term investments were $180.6 million, totaling $568.7 million. The company had $93.9 million of net receivables and $137.8 million of inventory. Convertible-note principal was $460 million; the balance-sheet carrying amount, net of financing costs, was $449.5 million. The notes bear 0% stated interest and mature in November 2026.
Healthcare Solutions revenue was $261.0 million, down 14.8%; Industrial Solutions revenue was $277.0 million, down 10.5%. Segment operating income was $25.8 million for Healthcare and $22.8 million for Industrial; corporate expenses drove the consolidated operating loss.
Material changes versus the prior comparable period
- Revenue fell 12.6%. Divestitures reduced revenue by $71.7 million and foreign-exchange movements by $24.1 million, partly offset by $17.0 million of higher sales volume.
- Gross margin declined 3.0 percentage points. Management cited divestitures, inflation and supply-chain pressure; Healthcare also faced lower dental-market volume.
- Operating expenses rose $34.4 million to $331.3 million, including higher acquisition-related and growth-investment costs, legal and settlement costs, and R&D spending. R&D increased 25.9% to $87.1 million.
- The 2021 net income included approximately $350.9 million of gains on business sales. The 2022 net loss therefore reflects both weaker operating results and the absence of those prior-year divestiture gains.
- Cash used in operations was $70.0 million versus $48.1 million provided in 2021, primarily reflecting higher operating losses and working-capital use, including inventory buildup. Cash and short-term investments together decreased $220.9 million.
Outlook, risks, contingencies and unusual items
- No numerical revenue, earnings or margin guidance is provided. Management expects cash flow, cash, short-term investments and other liquidity sources to be sufficient for foreseeable requirements, while noting that future investment and development spending is expected.
- 2022 acquisitions included Titan, Kumovis and dp polar. Management said each was expected to be dilutive near term. The company also invested $10 million in Enhatch and recorded a $2.8 million impairment after weaker-than-expected revenue and delayed regulatory approvals.
- Operating cash flow and liquidity may be affected by supply-chain disruption, uneven sales timing, inflation, foreign-exchange exposure and dependence on a large customer that represented 23% of 2022 revenue.
- The company reported two continuing material weaknesses in internal control over financial reporting: controls over revenue, receivables and deferred revenue, including contract-term entry, and review of internally prepared closing reports. Management and the auditor concluded controls were ineffective at year-end; the auditor issued an adverse opinion on internal control. The financial-statement audit opinion was unqualified. Remediation is underway, but timing is not assured.
- On February 27, 2023, the company settled export-control matters with DDTC, BIS and DOJ. It agreed to $15.0 million in civil penalties and up to $10.0 million in suspended penalties tied to required remediation; the suspended amount is recognized as incurred if not spent on those measures. A $16.0 million liability was recorded at December 31, 2022. The company also disclosed an ongoing OFAC matter and a securities class-action settlement that remained subject to court approval, as well as related derivative litigation.
- Other notable obligations include $65.3 million of existing lease obligations and $33.4 million of leases not yet commenced. A possible Volumetric acquisition earnout of up to $355 million depends on milestones and continued employment; most milestones were not considered probable at year-end.
Important facts for investors to verify
- Whether the material weaknesses are remediated and controls become effective, especially for revenue recognition and financial close.
- Progress toward sustained positive operating cash flow, inventory normalization and profitable growth in both segments.
- Customer concentration, order timing and the effects of currency movements, inflation and supplier availability.
- Cash requirements and potential dilution or cash settlement obligations related to the $460 million convertible notes, acquisitions, earnouts and planned investments.
- Final costs and compliance obligations under the export-control settlements; status of the OFAC matter and court approval of the securities settlement.